AMAG Pharmaceuticals is a pharmaceutical company that develops and delivers medicines across a range of therapeutic areas. Its core products include Makena, a hydroxyprogesterone caproate injection that helps reduce the risk of preterm birth in women with a singleton pregnancy, and Feraheme, a ferumoxytol injection for the treatment of iron deficiency anemia (IDA) in adult patients.